Increasing the number of cancer cases associated with increased government funding for R & D activities is expected to be a driver in future markets. The use of live cell imaging in the field of personalized medicine is expected to provide growth opportunities in the live cell imaging market during the forecast period.
Live cell imaging is a technology for studying live cells using images acquired from high content screening systems and imaging systems such as microscopes. Scientists use this method to better understand the biological functions of cells by studying cell dynamics. In recent years, live cell imaging technology has been widely accepted by various researchers to gain better knowledge of cell biology. Live cell imaging plays an important role in research fields such as neurology, immunology, microbiology, and genetics.
Get a PDF sample copy: https://www.theinsightpartners.com/sample/TIPHE100001215/
This report analyzes the factors affecting the live cell imaging market from both supply and demand aspects, and market dynamics that impact the market during the forecast period, ie drivers, restraints, opportunities, and future trends Assess further. The report also provides a comprehensive analysis of PEST for all five regions. North America, Europe, APAC, MEA, and South and Central America evaluated the political, economic, social and technical factors affecting the live cell imaging market in these regions.
List of companies
1. Thermo Fisher Scientific Inc.
2. PerkinElmer Inc.
3. General Electric
4. Olympus Corporation
5. BioTek Instruments, Inc.
6. Molecular Devices, LLC.
7. Sight Secreton Co., Ltd.
9. Nikon Instruments Inc.
10. Merck KGaA
The global live cell imaging market is segmented based on product, technology, application, and end user. Based on products, the market is segmented into instruments, kits and reagents, software and consumables. Based on technology, the global live cell imaging market is segmented into fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high content analysis, fluorescence in situ hybridization, and more. Based on application, the market is segmented into drug discovery, cell biology, developmental biology, stem cells and more. Based on end-users, the market is segmented into pharmaceutical and biotech companies, hospitals, diagnostic laboratories and more.
Buy a complete report with a comprehensive table of contents @ https://www.theinsightpartners.com/buy/TIPHE100001215/
This report provides a detailed overview of the industry including qualitative and quantitative information. It provides an overview and forecast of the global live cell imaging market based on various segments. It also provides market size and forecasts from 2017 to 2027 for five major regions. North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), South America and Central America. Each region’s live cell imaging market is later broken down by country and segment. This report covers the current trends and opportunities that are common in the region, as well as analysis and forecasts from 18 countries around the world.
Insight Partners is a one-stop industry research provider of actionable intelligence. We help customers get solutions to their research requirements through syndicated and consulting research services. We are technology, healthcare, manufacturing, automotive and defense specialists.
Phone: + 1-646-491-9876